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Role of phosphatase of regenerating 
liver 1 (PRL1) in spermatogenesis
Yunpeng Bai1, Hong-Ming Zhou2, Lujuan Zhang2, Yuanshu Dong2,†, Qi Zeng3, Weinian Shou4 & 
Zhong-Yin Zhang1,2
The PRL phosphatases are oncogenic when overexpressed but their in vivo biological function is less 
well understood. Previous gene deletion study revealed a role for PRL2 in spermatogenesis. We report 
here the first knockout mice lacking PRL1, the most related homolog of PRL2. We found that loss of 
PRL1 does not affect spermatogenesis and reproductive ability of male mice, likely due to functional 
compensation by the relatively higher expression of PRL2 in the testes. However, PRL1−/−/PRL2+/− 
male mice show testicular atrophy phenotype similar to PRL2−/− mice. More strikingly, deletion of one 
PRL1 allele in PRL2−/− male mice causes complete infertility. Mechanistically, the total level of PRL1 
and PRL2 is negatively correlated with the PTEN protein level in the testis and PRL1+/−/PRL2−/− mice 
have the highest level of PTEN, leading to attenuated Akt activation and increased germ cell apoptosis, 
effectively halting spermatozoa production. These results provide the first evidence that in addition to 
PRL2, PRL1 is also required for spermatogenesis by downregulating PTEN and promoting Akt signaling. 
The ability of the PRLs to suppress PTEN expression underscores the biochemical basis for their 
oncogenic potential.
The Phosphatases of Regenerating Liver (PRL1, 2 and 3) constitute a novel class of prenylated phosphatases 
within the protein tyrosine phosphatase superfamily1–3. PRL1 was initially identified as an immediate early gene 
during liver regeneration1. PRL2 and PRL3 were subsequently discovered by their sequence similarity to PRL14. 
PRL1 and PRL2 are most similar in amino acid sequence, exhibiting 87% identity, while PRL3 is 76% and 79% 
identical to PRL1 and PRL2, respectively4,5. Among the three PRL isoforms, PRL1 and PRL2 are expressed ubiq-
uitously across all tissues with PRL1 levels being slightly more restricted and less abundant than PRL24,6–8. PRL3 
was initially found primarily in heart and skeletal muscle4,6, although a recent study revealed a more broad but 
low expression pattern for PRL39.
Unlike other protein phosphatases that function to antagonize the action of protein kinases, PRLs play a 
positive role in cell signaling and rank among the most oncogenic phosphatases5,10. PRLs are overexpressed in 
many tumor cell lines, and cells expressing high levels of PRLs exhibit increased proliferation, migration and 
anchorage-independent growth1,2,11–14. Results from in vitro studies indicate that PRLs promote cell proliferation 
and migration through activation of several signaling pathways, such as the Rho family of small GTPases, Src, 
ERK1/2, and PI3K14–18. Clinically, up-regulation of PRLs has been associated with many types of advanced stage 
tumors as well as metastatic lesions and elevated PRL expression is often correlated with increased tumor inva-
siveness and poor prognosis5,19. However, in spite of the strong cancer connection, the roles of PRLs in normal 
physiology are not well understood. To begin to uncover the physiological significance of the PRL phosphatases, 
both PRL2 and PRL3 knockout mice have been generated. Deletion of PRL2, the most ubiquitously and abun-
dantly expressed PRL family member, leads to growth retardation in both embryos and adult mice and PRL2−/− 
mice display placenta insufficiency20, impairment of spermatogenesis21, and defects in hematopoietic stem cell 
self-renewal22. Biochemically, all three phenotypes associated with PRL2 deletion are caused by decreased Akt 
phosphorylation as a result of up-regulation of the tumor suppressor PTEN. Intriguingly, a role for PRL2 in 
modulating intracellular Mg2+ level through Mg2+ transporter CNNMs was also proposed23. Interestingly, recent 
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studies suggested that CNNMs may also play a role in reproduction and sperm function24,25. In contrast, mice 
deficient for PRL3 were grossly normal, although PRL3-null mice treated with carcinogenic azoxymethane and 
dextran sodium sulfate developed 50% fewer colon tumors than the wild-type, corroborating a potential role of 
PRL3 in colon tumorigenesis9,26. Nothing is known about the physiological function of PRL1 due in part to the 
absence of informative animal models.
Here, we describe the creation and characterization of PRL1 knockout mice. In contrast to what has been 
reported for the PRL2−/− mutant animals, PRL1 deficient mice developed normally and did not exhibit any obvi-
ous phenotypic alteration. To further investigate the role of PRL1 in vivo, we sought to generate mice lacking both 
PRL1 and PRL2. This was based on the fact that PRL1 is more closely related to PRL2 and shares similar tissue 
distribution with PRL2. Unfortunately, PRL1/PRL2 double knockout mice were embryonic lethal, indicating a 
critical requirement for both PRL1 and PRL2 in mouse embryonic development. However, PRL1−/−/PRL2+/− and 
PRL1+/−/PRL2−/− mice are viable, which enabled us to interrogate the function of PRL1 in spermatogenesis. 
We report that the testicular atrophy previously observed in PRL2−/− mice is also found in PRL1−/−/PRL2+/− 
mice, and this phenotype is further aggravated in PRL1+/−/PRL2−/− mice. Mechanistically, the testis of PRL1+/−/
PRL2−/− mice has the highest level of PTEN, leading to attenuated Akt activation and increased germ cell apop-
tosis. These results provide the first evidence that in addition to PRL2, PRL1 is also required for spermatogenesis 
by regulating the PTEN/Akt signaling pathway, and support the notion that there is a functional redundancy 
between PRL1 and PRL2, leading to a “PRL1/2-dose”-dependent phenotype in vivo.
Results and Discussion
Creation of PRL1 mutant mice. To begin to delineate the physiological function of PRL1, we generated 
PRL1 knockout mice using a gene trap ES cell clone (CC0606) containing an insertional mutation in the mouse 
PRL1 locus from Mutant Mouse Regional Resource Centers (MMRRC)20. The gene trap vector containing a 
reporter gene β -galactosidase/neomycin (β -Geo) ORF flanked by an upstream splice-acceptor sequence and 
a downstream premature polyadenylation signal was inserted into the exon 2 of PRL1 (Figure S1A), which 
should abrogate transcription of PRL1 exons 2 to 6. Since the insertion site is upstream of the translation start 
codon for PRL1 within exon 2, the insertion of the gene trap vector would completely eliminate endogenous 
PRL1 expression. The offspring of the PRL1 gene trapped chimera were confirmed for successful germline 
transmission as evidenced by genotyping with the heterozygous alleles. Breeding the F1 heterozygous mice 
gave offspring with all three genotypes including PRL1 wild-type, heterozygous and homozygous deletion 
animals (Figure S1C).
To confirm PRL1 gene deletion, we first examined PRL1 at the mRNA level by quantitative RT-PCR. Total 
mRNAs were extracted from the thymus of either wild-type, PRL1-null or PRL2-null mice to confirm the deletion 
of PRL1 or PRL2. As shown in Figure S2A, PRL1 or PRL2 mRNA was not detectable in the knockout samples. 
Deletion of PRL1 or PRL2 protein was also confirmed by Western blot analysis using a PRL1/2 antibody, an anti-
body that recognizes both PRL1 and PRL220,21. To evaluate the affinity and specificity of the PRL1/2 antibody, we 
measured its ability to detect recombinant PRL1, PRL2 and PRL3 proteins (Figure S2B). The results showed that 
this antibody binds PRL1 and PRL2 with the same affinity but its affinity for PRL3 is at least 100-fold lower. Since 
PRL2 is 6 amino acids shorter than PRL1, the PRL1/2 antibody can be used to distinguish endogenous PRL1 and 
PRL2 based on their difference in size. This allows assessment of the relative levels of PRL1 and PRL2 in tissues 
as well as potential changes in PRL2 levels upon PRL1 deletion. Therefore, tissue lysates from lung and spleen of 
either wild-type, PRL1−/− or PRL2−/− mice were surveyed for the presence of PRL1 and PRL2 using the PRL1/2 
antibody. While endogenous PRL1 and PRL2 are clearly detectable in the wild-type samples, they are absent in 
those from the respective PRL1-null and PRL2-null mice (Figure S2C). Taken together, these results confirm 
PRL1 deletion with the “gene-trapped” approach.
Phenotypic analysis of PRL1 knockout mice. To characterize the phenotype of mice lacking PRL1, we 
first examined the birth rate of the PRL1 deficient mice by analyzing nearly 700 pups produced by heterozygous 
mating. Although all possible genotypes were observed in the resulting offspring, the segregation of the PRL1 
knockout alleles did not exactly follow the expected Mendelian ratio of 1:2:1 (Table 1). Among the 683 and 519 
pups produced by PRL1 and PRL2 heterozygous mating, only 143 and 73 animals were identified as knockouts. 
These numbers were significantly less than what would be expected for a normal Mendelian distribution of 170 
and 130, respectively, for PRL1−/− and PRL2−/−. This observation suggests that deletion of either PRL1 or PRL2 
presents a survival disadvantage to the animal.
+/+ +/− −/− n χ2 p
PRL1
Observed 187 353 143
683 6.44 < 0.05
Expected 171 342 171
PRL2
Observed 139 307 73
519 34.18 < 0.001
Expected 130 260 130
Table 1. Distribution of offspring by PRL1 or PRL2 heterozygous-heterozygous mating at weaning 
indicates a survival disadvantage of PRL1 and PRL2 knockout mice.
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We then measured the body weight of more than 20 males and females with different genotypes at wean-
ing (4 weeks old). In contrast to PRL2−/− mice, which exhibit a 20% decreased body weight in comparison to 
their wild-type counterparts20, the body weight of PRL1−/− mice was not significantly different from that of the 
wild-type (Figure S3A,B). As reported previously21, testis from PRL2−/− males was significantly smaller even 
when normalized to the whole body weight (Figure S3C). However, a similar organ/whole body weight ratio was 
observed for both PRL1−/− mutant and wild-type controls (Figure S3C,D). Histological analysis was performed 
on tissue sections by hematoxylin and eosin staining, and no significant abnormalities were observed in all geno-
types (Figure S3E). These data indicate that deletion of PRL1 does not alter overall mouse phenotypes.
Generation and characterization of PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice. Given the 
lack of apparent phenotype for the PRL1−/− mice, we suspected that there might be functional redundancy among 
the PRLs. Since PRL1 is most homologous to PRL2 (87% amino acid sequence identity) and exhibits a similar 
expression pattern to that of PRL2, we sought to generate mice lacking both PRL1 and PRL2 in order to assess 
whether the two phosphatases play similar roles in signaling. Mice heterozygous for both PRL1 (Figure S1A,C) 
and PRL2 (Figure S1B,C) were intercrossed to generate PRL1−/−/PRL2−/− double knockout mice. However, after 
analysis of more than 300 pups from the PRL1+/−/PRL2+/− cross, none of the offspring were found to be PRL1−/−/
PRL2−/− double knockouts (Table 2). This result suggests that mice lacking both PRL1 and PRL2 are embryonic 
lethal. To investigate at which stage the embryos were dead, we carried out time mating to harvest embryos at 
E17.5, E14.5, E11.5 and E9.5 days. Unfortunately, we could not identify any viable double knockout mice at these 
stages, indicating early embryonic lethality in the absence of both PRL1 and PRL2.
Given the lower expression of PRL1 relative to PRL2, loss of PRL1 may be compensated by the remaining PRL2, 
whereas loss of PRL2 cannot be fully rescued by PRL120–22. However, since mice deficient in both PRL1 and PRL2 
were embryonic lethal, we hypothesized that PRL1 and PRL2 have similar functions during development and that 
the combined total level of PRL1 and PRL2 dictates phenotype severity. To test this hypothesis, we then generated 
PRL1+/−/PRL2−/− mice and PRL1−/−/PRL2+/− mice. These mice also displayed a survival disadvantage as evidenced 
by the reduced birth rate (Table 2). PCR analysis was used to determine the deletion of PRL1 and PRL2 alleles 
(Fig. 1A). Deletion of the PRL protein was confirmed by Western blot on lung lysates from mice with different geno-
types using PRL1/2 antibody (Fig. 1B). To examine the expression pattern of all PRLs, protein lysates from different 
organs were subjected to Western blot analysis using PRL1/2 and PRL3 antibodies. As shown in Figure S4A, both 
PRL1 and PRL2 are broadly expressed in all the organs we assayed. However, endogenous PRL3 is only moderately 
detectable in brain, lung, colon, small intestine, spleen, thymus, muscle and heart, which is consistent with the most 
recent report9. Given the same affinity and specificity of the PRL1/2 antibody towards PRL1 and PRL2, the intensity 
of the PRL1 band (upper band) and PRL2 band (lower band) reflects the relative level of endogenous PRL1 and 
PRL2. Overall, the level of PRL1 protein is lower than PRL2 in the organs we measured, from ~40% of PRL2 in testis 
to ~5% of PRL2 in muscle (Figure S4B). Supplemental Table 1 lists the combined PRL1 and PRL2 level relative to 
that of the wild-type in different organs of mice with different genotypes.
To characterize the overall phenotypic changes associated with PRL1/2 deletion, we first measured the body 
weight of more than twenty 4-weeks-old males and females with different genotypes. As mentioned above, 
PRL2−/− mice exhibited a roughly 20% decrease in body weight compared with wild-type and PRL1−/− mice. 
More strikingly, the body weights of PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− male mice decreased 38 ± 13% and 
41 ± 10% in comparison with that of the wild-type males, and an additional 23 ± 16% and 27 ± 12% reduction 
was observed when compared to the body weight of PRL2−/− males. Similarly, the body weights of PRL1−/−/
PRL2+/− and PRL1+/−/PRL2−/− females were also decreased 30 ± 13% and 26 ± 14% compared to the wild-type 
controls (Fig. 1C,D). These observations revealed that the smaller body weight phenotype previously observed in 
PRL2−/− mice was significantly intensified in PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice.
Both PRL1 and PRL2 contribute to male reproductive ability. One of the major phenotypes for 
PRL2−/− mice is testicular atrophy21. Interestingly, both PRL1 and PRL2, but not PRL3, are expressed in testis, and 
the relative PRL1/PRL2 protein level is significantly higher in testis than those from other organs (Figure S4A). 
This finding suggests that PRL1 and PRL2, but not PRL3, may play essential roles in testis function. To determine 
whether both PRL1 and PRL2 are required for spermatogenesis, we focused on the testis phenotype in PRL1−/−/
PRL2+/− and PRL1+/−/PRL2−/− mice. Anatomical examination was performed on adult males of different geno-
types. Similar to our previous study21, the testis of PRL2 null mice is 43 ± 8% smaller than that of wild-type mice 
(Fig. 2A,B). Strikingly, deletion of a single allele of PRL1 gene from the PRL2-null mice caused an additional 
59 ± 16% reduction of testis size, indicating that PRL1 is indeed involved in testis development (Fig. 2A,B). This 
is further strengthened by the observation that the testes of PRL1−/−/PRL2+/− male mice were also markedly 
smaller than those of wild-type animals (33 ± 14% reduction) (Fig. 2A,B), despite the fact that testis development 
in either PRL1−/− or PRL2+/− mice is normal. Since the body weight of PRL1−/−/PRL2+/− and especially PRL1+/−/
PRL1 +/+ +/− −/−
n χ2 pPRL2 +/+ +/− −/− +/+ +/− −/− +/+ +/− −/−
Observed 22 56 30 54 110 27 18 35 0
352 45.10 < 0.001
Expected 22 44 22 44 88 44 22 44 22
Table 2. Distribution of offspring by double heterozygous-double heterozygous (PRL1+/−/PRL2+/−) 
mating at weaning indicates embryonic lethality of PRL1−/−/PRL2−/− double knockout mice and a survival 
disadvantage of PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice.
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PRL2−/− male mice was also reduced (Fig. 1C), we normalized the testis weight to body weight and still found a 
significant reduction of the testis/body weight ratio in PRL1−/−/PRL2+/− and especially PRL1+/−/PRL2−/− mice. 
As shown in Fig. 2C, while the testis/body weight ratio observed in PRL2−/− males decreased 33 ± 16% compared 
to the wild-type animals, deletion of one more PRL1 allele resulted in a 69 ± 9% reduction in the normalized testis 
Figure 1. Generation of PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice. (A) PCR strategy for genotyping 
using mouse tail DNA. (B) Endogenous PRL1 and PRL2 protein products were determined by Western blot on 
lung lysates from different genotypes. (C,D) Body weights of 4-weeks-old male mice (C) or female mice (D) 
with different genotypes were determined. Body weights of PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− 
males and females were significantly less than those of wild-type and PRL1−/− males and females. Body weights 
of PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− males were also significantly less than those of PRL2−/− males. 
**p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of at least three independent experiments 
(mean and SD).
Figure 2. PRL1 also contributes to the normal testis development. (A) Representative testis picture from 
five different genotypes. (B,C) Testis weights (B) or testis weight/body weight ratios (C) from five different 
genotypes were determined. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of at 
least three independent experiments (mean and SD).
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size. Moreover, although no significant difference was observed in PRL1−/− mice, the testis/body weight ratio of 
PRL1−/−/PRL2+/− testis reduced 19 ± 12% compared to the wild-type mice (Fig. 2C).
To determine whether the reduced testis size affects male reproductivity, 3-months-old PRL1−/−/PRL2+/− and 
PRL1+/−/PRL2−/− male mice were mated with wild-type virgin females. These mice showed similar sexual desire 
as measured by the percentage of female mice plugged by the males (Fig. 3A). However, the percent pregnancy as 
well as the litter size from the PRL1−/−/PRL2+/− mice group were significantly lower than those of the wild-type 
Figure 3. Deletion one PRL1 allele in PRL2−/− results in male infertility due to no sperm production.  
(A) Sexual desire was measured by plug rate. (B,C) Reproductive performance was measured by pregnancy rate 
(B) and little size (C). (D) The sperm number was determined by calculating the sperms from epididymis.  
(E) Caudal epididymis sections from 3 months old male mice were histologically examined by H&E staining. 
Scale bar = 50 μ m. (F) Electron microscopic analysis of epididymal sperm from the indicated genotypes. 
The typical “9 + 2” microtubule structure indicates the transverse section of the sperm. Scale bar = 500 nm. 
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of at least three independent 
experiments (mean and SD).
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(Fig. 3B,C). More strikingly, none of the females that were plugged by PRL1+/−/PRL2−/− male mice were preg-
nant, indicating that a single PRL1 allele deletion in PRL2 deficient mice results in male infertility (Fig. 3B,C). To 
further characterize the functionality of the testis, the number of spermatozoa from the epididymis of 3-months 
old male mice was counted using a hemocytometer. In agreement with previous findings21, the number of sperms 
from the PRL2−/− mice was only 54 ± 18% of the wild-type controls (Fig. 3D). Similarly, the PRL1−/−/PRL2+/− 
mice also had significantly decreased sperm counts (68 ± 9% of wild-type) (Fig. 3D), suggesting that both PRL1 
and PRL2 contribute to sperm production. Not surprisingly, PRL1+/−/PRL2−/− male mice lost 93 ± 5% of sperms 
in the epididymis (Fig. 3D), which explained their sterility. Consistent with this observation, H&E staining on 
caudal epididymis, where mature spermatozoa accumulate, failed to reveal any morphologically normal sperma-
tozoa in the epididymis of PRL1+/−/PRL2−/− mice (Fig. 3E). Although more round-shaped non-spermatozoa cells 
were also found in the epididymis of PRL2−/− and PRL1−/−/PRL2+/− mice, most of the cells were morphologically 
normal spermatozoa (Fig. 3E). To further characterize the structural defects of spermatozoa in the epididymis, 
we performed transmission electron microscopy (TEM) analysis. We found that sperms in PRL1 knockout mice 
displayed similar density and structural features as the sperms in the wild-type. In both PRL2−/− and PRL1−/−/
PRL2+/− mice, some sperms were released as a cluster, indicating that these sperms failed to complete cell divi-
sion. As expected, sperms were rarely observed in PRL1+/−/PRL2−/− mice, and immature spermatocytes were 
released into epididymis, indicating increased germ cell apoptosis (Fig. 3F). Taken together, the data suggest that, 
in addition to PRL2, PRL1 also controls sperm production, which directly affects male reproductive ability. Given 
that the total levels of PRL1/2 in the testis of PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice 
are 70%, 30%, 35% and 15% of that of the wild-type, respectively (Supplemental Table 1), the data support our 
hypothesis that the reduction of the combined level of PRL1 and PRL2 correlates with the severity of testicular 
atrophy phenotype and the impairment of reproductive ability of male mice.
To further establish the functional redundancy between PRL1 and PRL2, we sought to demonstrate that the addi-
tional phenotypic defects caused by PRL1 deletion could be rescued by re-introduction of PRL2. To this end, we pro-
ceeded to generate a conditional PRL2 transgenic line (Supplemental Information). However, when we crossed the 
conditional PRL2 transgenic line to the whole body EIIA-Cre line (Figure S5A), we found that the PRL2 transgene 
was only expressed in the testis (Figure S5B). Although we do not understand why and how this happened, one pos-
sibility is that the increase levels of PRL2 in normal tissues may be intrinsically deleterious to normal cells, and conse-
quently selected against in other tissues. Fortunately, this testis-specific PRL2 transgenic line (PRL2Testis) enabled us to 
test our hypothesis that the phenotype caused by PRL1 deletion could be rescued by re-expressing PRL2. To this end, 
we crossed the PRL2Testis line with PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice. Western blot analysis indi-
cated that the PRL2 transgene was expressed at ~50% of endogenous PRL2 in testis (Figure S5C). More importantly, 
the impaired reproductive ability and reduced testis weight phenotypes observed in PRL2−/−, PRL1−/−/PRL2+/− and 
PRL1+/−/PRL2−/− mice were rescued upon re-introduction of the PRL2 transgene (Figure S5D,E), suggesting that 
PRL1 deletion-induced defects in testis could indeed be rescued by re-expressing of PRL2.
Total PRL1 and PRL2 level are important for maintaining spermatogenesis. To further inves-
tigate how PRL1 is involved in controlling testis organ size and sperm production, the histological structures of 
3-month-old male testis derived from different genotypes were analyzed by H&E staining. Even though the overall 
structures of the seminiferous tubules of 3-month-old male mice were similar between the different genotypes, the 
diameters of the seminiferous tubules were altered (Fig. 4A,B). Consistent with our previous study21, the diameter 
of the seminiferous tubules from the PRL2−/− testis decreased 21 ± 6% in comparison to those from the wild-type 
and PRL1−/− mice. There was also a 17 ± 3% and 27 ± 5% reduction in the diameter of the seminiferous tubules 
of the PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− testis, respectively (Fig. 4B). Moreover, loss of certain cell types 
was evidenced by the “empty space” observed inside of the seminiferous tubules of PRL2−/− testis, and this was 
even more severe in the PRL1+/−/PRL2−/− testis (Black arrows in Fig. 4A). In line with this observation, numerous 
round-shaped cells were released into the caudal epididymis of PRL2−/− mice, and even more round-shaped cells 
were observed in the caudal epididymis of PRL1+/−/PRL2−/− mice (Fig. 3E). In addition, re-expressing PRL2 in the 
testis successfully rescued the histological abnormality in PRL1+/−/PRL2−/− testis (Figure S5F, top panel). These 
data indicated that the combined level of PRL1 and PRL2 is important for maintaining spermatogenesis and that the 
reduced testis size is mainly attributed to decreased cellularity in the seminiferous tubules.
To determine exactly which cell population is affected in the testis of different genotypes, we first examined 
the Sertoli cell number by Vimentin staining (previously used as a marker for Sertoli cell)27. As shown in Fig. 4A, 
the number of Sertoli cells from the 3-month-old male testis of the five genotypes was comparable (Fig. 4A,C), 
suggesting that the reduced cellularity is not due to loss of Sertoli cells. We then examined the germ cell number 
by PLZF staining (a specific marker for undifferentiated spermatogonia) and Kit staining (a specific marker for 
differentiating spermatogonia and primary spermatocytes)28,29. Our previous study of the PRL2−/− mice sug-
gested that differentiating spermatogonia and primary spermatocytes (Kit positive), but not undifferentiated 
spermatogonia (PLZF positive), were significantly reduced in PRL2−/− testis at 2-week-old21. We speculated that 
deletion of one more PRL1 allele in PRL2−/− testis will further aggravate the loss of Kit-positive cells. As shown 
in Fig. 4A,D,E, the number of PLZF-positive cells is comparable in all five genotypes, but the Kit-positive cell 
numbers varied between genotypes, suggesting that deletion of PRL1 and PRL2 primarily impact differentiating 
spermatogonia and primary spermatocytes. Consistent with our previous findings21, the number of Kit-positive 
cells in PRL2−/− testis dropped 30 ± 4% of the wild-type controls (Fig. 4A,D). Comparable to the PRL2−/− testis, 
the Kit-positive cell number also decreased 35 ± 10% in the PRL1−/−/PRL2+/− testis (Fig. 4A,D). As expected, 
loss of Kit-positive cells was more pronounced in the PRL1+/−/PRL2−/− testis (58 ± 8% less than the wild-type), 
in which many tubules are completely empty compared to the PRL2−/− and PRL1−/−/PRL2+/− testis (Fig. 4A,D). 
Taken together, the combination of PRL1+/− and PRL2−/− intensified the Kit-positive germ cell loss observed in 
PRL2−/− testis, leading to a complete blockage of spermatogenesis and infertility.
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Sufficient level of total PRL1 and PRL2 are required to prevent germ cells from ectopic apoptosis. 
Spermatogenesis is a precisely controlled process including germ cell proliferation, differentiation, self-renewal 
Figure 4. PRL1 also plays a role in maintaining spermatogenesis. (A) Testis sections from 3 months or 2 
weeks old male mice were histologically examined by H&E staining and immunohistochemical staining for 
Vimentin, PLZF and Kit. (B–E) Relative seminiferous tubule diameters (B), number of Vimentin positive cell 
per seminiferous tubule (C), number of c-Kit positive cell per tubule (D) and number of PLZF positive cell per 
tubule (E) in testis sections from all five genotypes were quantificated. For each mouse, at least 20 tubules were 
counted. *p < 0.05, **p < 0.01 (Student’s t test). Data are representative of at least three independent experiments 
(mean and SD). Scale bar = 50 μ m.
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and apoptosis. Germ cell loss occurs normally during spermatogenesis in all mammals, and control of germ 
cell apoptosis during spermatogenesis is especially important. To determine whether loss of Kit-positive germ 
cells was due to decreased proliferation or increased apoptosis, we performed immunohistochemistry with 
PCNA (Proliferating Cell Nuclear Antigen, a proliferation marker) staining and cleaved PARP (Poly ADP-Ribose 
Polymerase, an apoptosis marker) staining to label proliferating and apoptotic cells respectively. As shown in 
Fig. 5A,C, the percentage of proliferating cells in the testis was similar in all five genotypes. In contrast, the 
number of cleaved PARP positive cells was 3-fold higher in PRL2−/− compared to wild-type or PRL1−/− testis 
(Fig. 5A,B). PRL1−/−/PRL2+/− mice also showed a 1.6 fold higher apoptosis compared to the control groups 
(Fig. 5A,B). More importantly, deletion of one PRL1 allele in PRL2−/− mice led to an additional 3-fold increase 
in apoptosis in comparison to PRL2−/− alone (Fig. 5A,B). The aggravated phenotype of PRL1+/−/PRL2−/− mice 
compared to PRL2-null mice further supports an important role of PRL1 in spermatogenesis by promoting 
Kit-positive germ cell survival.
Total PRL1 and PRL2 level negatively correlates with PTEN level. PI3K/Akt is the major pathway 
that regulates the proliferation and survival of differentiating spermatogonia and spermatocytes30,31, and Akt1 
knockout males exhibit impaired reproductive ability due to increased germ cell apoptosis32. Deletion of PRL2 
leads to compromised Akt activation due to elevated PTEN21. To evaluate whether deletion of PRL1 also affects 
the PTEN/PI3K/Akt pathway, we next investigated the signaling pathways in whole testis lysate by Western blot. 
Similar to what we observed in PRL2−/− mice, the testis from PRL1−/−/PRL2+/− mice also showed increased 
PTEN level and reduced Akt activation (Fig. 6A). More strikingly, deletion of one PRL1 allele in PRL2−/− mice 
further elevated the PTEN level and reduced pAkt, leading to more PARP cleavage (Fig. 6A). To further sub-
stantiate that the total PRL1 and PRL2 level negatively regulates PTEN expression in testis, we determined the 
total PRL1/2 and PTEN level as well as Akt activation in isolated germ cells by Western blot from all five gen-
otypes (n = 6 for each genotype, Fig. 6B). Similar to the results from whole testis (Supplemental Table 1), the 
total PRL1/2 levels in germ cells isolated from PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice 
were 65 ± 7%, 29 ± 6%, 32 ± 6%, and 13 ± 2% of the wild-type controls (100 ± 4%). As expected, relative PTEN/
Actin levels in germ cells isolated from PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice were 
Figure 5. PRL1 is also required to prevent germ cells from apoptosis. (A) Testis sections from 3 month 
old male mice were histologically examined by immunohistochemical staining for Cleaved PARP and PCNA. 
(B,C) Number of cleaved-PARP positive cell per field (B) and percentage of PCNA positive cells per tubule 
(C) in testis sections from five genotypes were determined. For each mouse, at least 10 fields or 20 tubules 
were counted. **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of at least three independent 
experiments (mean and SD). Scale bar = 50 μ m.
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Figure 6. Total PRL1 and PRL2 negatively correlated with PTEN. (A) Alterations of key signaling pathway 
molecules in testis from different genotypes by Western blot. (B) Upper panel: germ cells isolated from testis 
of male mice with different genotypes were analyzed for PTEN, pAkt, Akt, Actin, PRL1 and PRL2 by Western 
blot. Lower panel: relative level of either PTEN/Actin, pAkt/Akt or total PRL1 and PRL2/Actin in isolated 
germ cells from different genotypes. (C) PTEN immunohistochemistry analysis in seminiferous tubules of 
testis with different genotypes. (D) Quantification of PTEN IHC staining by ImageJ IHC Image Analysis 
Toolbox. *p < 0.05 (Student’s t test) compared to wild-type; #p < 0.05 (Student’s t test) compared to PRL2−/− and 
PRL1−/−/PRL2+/−. Scale bar = 50 μ m.
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20 ± 23%, 39 ± 33%, 46 ± 34%, and 78 ± 26% higher than that of the wild-type (100 ± 19%). Consistently, the 
relative pAkt/Akt levels in germ cells isolated from PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− 
mice were 102 ± 21%, 73 ± 16%, 70 ± 19%, and 45 ± 17% of the wild-type (100 ± 18%). Consistently, immunohis-
tochemistry analysis also revealed elevated PTEN in PRL2−/−, PRL1−/−/PRL2+/− and, most strikingly, PRL1+/−/
PRL2−/− testes (Fig. 6C,D). Moreover, re-expression of the PRL2 transgene in PRL1+/−/PRL2−/− testes success-
fully reduced PTEN level (Figure S5C,F, middle and bottom panels). Collectively, the data indicate that PRL1, like 
PRL2, is also involved in PTEN downregulation and there is a negative correlation between the total PRL1/2 level 
and the PTEN level.
Given the significant role of PTEN in down-regulating PI3K/Akt signaling pathway, it is understandable 
that loss of heterozygosity in PTEN+/− mice causes spontaneous tumorigenesis including testicular germ cell 
cancer33. PTEN is one of the most well-known tumor suppressors that are frequently mutated, and commonly 
down-regulated in cancer34. Loss of function PTEN mutations or even a 20% reduction in PTEN expression can 
amplify PI3K signaling and promote tumorigenesis in a variety of experimental models of cancer35. It has been 
previously reported that loss of PTEN leads to testicular teratoma36. To further evaluate the clinical relevance 
of our observed negative correlation between PTEN and PRL1 and PRL2, we analyzed PRL1, PRL2 and PTEN 
mRNA level in normal and testicular cancer patient samples from a publicly available microarray dataset using 
the Affymetrix U133A platform37. We found that both PRL1 and PRL2 level are significantly elevated, while 
PTEN level is significantly decreased in testicular cancer patients (n = 184) compared to normal testis samples 
(n = 13) (Figure S6). Taken together, our finding that both PRL1 and PRL2 are involved in the negative regulation 
of PTEN offers a plausible explanation for the positive roles played by PRL1 and PRL2 in promoting cell prolif-
eration and survival as well as tumorigenesis. Together with the previous finding that PRL3 also down-regulates 
PTEN through increasing its degradation17, our studies also suggest that the oncogenic potential of all PRLs is 
underscored by their ability to down-regulate PTEN thereby activating the Akt pathway.
In summary, our study suggests that the lack of significant phenotypic effect of PRL1 deletion could be 
explained, in part, by an insufficient decrease in the combined level of PRL1 and PRL2, due to the relatively lower 
PRL1 versus PRL2 expression. Our study also elucidates a previously undescribed cooperative function of both 
PRL1 and PRL2 in spermatogenesis by regulating PTEN/Akt signaling pathway. Our results not only suggest an 
essential role of both PRL1 and PRL2 in testicular development by maintaining spermatogonia stem cell survival, 
but also indicate a potential disease mechanism in which overexpression of PRL1 and PRL2 results in reduced 
PTEN level in testis, thereby leading to testicular cancer. From a clinical point of view, PRL1 and PRL2 may be 
potential biomarkers and therapeutic targets for testicular cancers and drug targets for male contraception.
Material and Methods
Animals. Generation of PRL2 deficient mice was described previously using “gene-trapping” method20. 
Heterozygous gene trap embryonic stem (ES) cell line (Cell No.: CC0606; Mouse strain: 129P2/OlaHsd) con-
taining an insertional mutation in mouse PRL1 locus was purchased from Mutant Mouse Regional Resource 
Centers (MMRRC). The ES cells were injected into blastocysts from C57BL/6J mice in the Transgenic and Knock-
Out Mouse Core at Indiana University Simon Cancer Center, and the resulting chimeric males with successful 
germ line transmission of the mutant allele were intercrossed with C57BL/6J females to generate F1 offspring. 
Genotyping of F1 offspring was performed by PCR. Genotyping primers used for detecting wild-type alleles 
are GCAGACAAGTGAACTGTAGAAATTC and AGTGTAGCACACTTCTACCGTTCCA, and for detecting 
mutant alleles are GCAGACAAGTGAACTGTAGAAATTC and ACGACGGGATCCTCTAGAG. PRL1+/−/
PRL2+/− intercrossing was used to generate PRL1−/−/PRL2+/− and PRL1+/−/PRL2−/− mice. Mice used in this 
study were all on a C57BL6/129P2 mixed genetic background. All experiments on mice were carried out in 
accordance with the Guide for Care and Use of Laboratory Animals of the National Institutes of Health, and 
animal protocols were approved by the Institutional Animal Care and Use Committees of Indiana University 
(Protocol Number 10504).
RNA extraction and quantitative RT-PCR. Total RNA was extracted from tissues using Trizol reagent 
(Invitrogen) and treated with DNase I (Promega). Reverse transcription was performed using the SuperScript 
III one-step RT-PCR system (Invitrogen) at 55 °C with gene-specific primers. Quantitative PCR was performed 
using SYBR Green I master mix on a LightCycler 480 (Roche Applied Science), with RPL7 as the housekeeping 
gene control. RT-PCR primers are GAAGAGGCCGTCTCCACTAA and ATCCCAGGATTGCGATTACA for 
detecting PRL1, GGCTGTAACAGGGTGGAAGA and GCCACCAACATCTGGGTACT for detecting PRL2, and 
GCTGCGGATTGTGGAGCCATAC and CCTCCATGCAGATGATGCCAAAC for detecting RPL7.
Western Blot analysis. Tissues were lysed in lysis buffer supplied with phosphatase and protease inhibitor 
mixture (Roche Applied Science). Equal amounts of protein were resolved by SDS-PAGE, transferred to nitro-
cellulose membrane and subjected to immunoblotting. Anti- PRL1, anti-PRL1/2 and anti-PRL3 antibodies were 
described in ref. 38. All other antibodies were from Cell Signaling Technology.
Reproductive performance evaluation. Age matched wild-type, PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− 
and PRL1+/−/PRL2−/− males were each mated with 4 wild-type virgin females every day for 6 consecutive days. 
Vaginal plugs were monitored every morning, and plugged females were removed and replaced with virgin 
females. After 6 days, the total number of females plugged by each male was counted. Plugged females were kept 
for an additional month to determine the number of pregnant mice and their litter sizes. The percentage of preg-
nant mice among the plugged and the average litter size were calculated for each male.
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Histology. Tissues were fixed in 4% paraformaldehyde (PFA) overnight at 4 °C, embedded in paraffin, 
serially sectioned (7 μ m), and stained with H&E according to standard methods. For immunohistochemistry, 
de-paraffined and hydrated sections were subjected to antigen retrieval by boiling in 10 mM sodium citrate for 
20 min. Sections were then incubated with diluted antibodies (1:50–1:400) at 4 °C overnight. Signals were detected 
by VECTASTAIN Elite ABC kit and developed using DAB substrate from Vector laboratory (Burlingame, CA). 
Antibodies used were PLZF, Kit (Santa Cruz Biotechnology, CA), Vimentin, PCNA, cleaved PARP and PTEN 
(Cell Signaling Technology, MA). Images were captured on a Leica DM2500 stereomicroscope. All images are 
representative of at least 3 samples.
Testicular cell isolation. Testes isolated from wild-type, PRL1−/−, PRL2−/−, PRL1−/−/PRL2+/− and 
PRL1+/−/PRL2−/− males were de-capsulated and digested in DMEM containing 1 mg/mL collagenase I at 32 °C 
for 20 min with gentle agitation. Released interstitial cells were removed, and seminiferous tubules were washed 
twice with DMEM. Seminiferous tubules were then subjected to second enzymatic digestion in DMEM with 
1 mg/mL collagenase I, 0.5 mg/mL trypsin, 50 U/mL hyaluronidase, and 100 μ g/mL DNase I at 32 °C for 30 min 
with gentle agitation. Seminiferous tubules were pipetted up and down for 10 times to disassociate the cells. The 
cell clumps were removed by passing through a 70 μ m nylon filter, and the single cell preparation was incubated 
in a culture dish in DMEM at 32 °C with 5% CO2 for 3 h to allow Sertoli cells and peritubular cells to attach. Germ 
cells in the suspension were then counted and used immediately.
Sperm count. Caudal epididymis were isolated from age-matched wild-type, PRL1−/−, PRL2−/−, PRL1−/−/
PRL2+/− and PRL1+/−/PRL2−/− males, minced in 10 mL BWW buffer (NaCl 5.54 g/L, KCl 0.356 g/L, CaCl2• 2H2O 
0.250 g/L, KH2PO4 0.162 g/L, MgSO4• 7H2O 0.294 g/L, NaHCO3 2.1 g/L, glucose 1.0 g/L, Sodium pyruvic acid 
0.03 g/L, BSA 3.5 g/L), and incubated at 32 °C for 15 min. After mixed by pipetting, the motile and total sperm 
numbers were counted using hemocytometer.
Statistical analysis. Statistical significant differences were calculated using student’s t-test or χ 2 test and 
represented by asterisks: *p < 0.05, **p < 0.01, ***p < 0.001.
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